RL Looks 15.9% Overvalued on GF Value™ as Insider Selling Persis
Ralph Lauren Corp (RL) announced a partnership with the Korea National Cancer Center Foundation to establish a cancer center in South Korea. RL is modestly overvalued by 15.9%, with a current price of $351.20 versus a GF Value™ of $303.11. The company has a GF Score™ of 92/100, indicating strong financial health and profitability, but has seen significant insider selling totaling $123.5 million over the past 12 months.
How this was made
The 30-second read
Why it matters
The article reiterates existing valuation metrics and insider sell‑off, offering limited new actionable insight.
Market read
Provides a modestly negative outlook for RL based on valuation gap and insider selling.
What to watch
Potential brand‑building benefits from the new Korean cancer center partnership.
Background
GuruFocus valuation and insider activity report for Ralph Lauren Corp.
Ticker impact
Insider selling of $123.5M over 12 months and a 15.9% overvaluation signal potential downside.
Potential short-term pullback or muted upside.
Large insider sell‑off combined with a valuation gap suggests limited upside until price aligns with intrinsic value.
Market effects
Highlights valuation concerns for consumer‑cyclical apparel peers.
Limited to U.S. equity market; no direct regional effect.
Minimal global impact beyond RL.
Counterpoint
Despite insider sales, the strong GF Score and growth metrics could support a hold for long‑term investors.
Key entities
- companyRalph Lauren Corp
US‑listed consumer‑cyclical apparel company (ticker RL).
